Associate Professor of Medicine, Johns Hopkins University School of Medicine; Director and Johs Hopkins Institute for Excellence in Education Professor of Medicine; Director, GIM Clinician-Educator Mentoring and Scholarship Program; Thayer Firm Faculty;
Internal Medicine
Dr. Joseph Cofrancesco, MD
Joseph Cofrancesco is an expert in the field of Internal Medicine. He studied medicine at Icahn School of Medicine at Mount Sinai. Icahn School of Medicine at Mount Sinai is ranked 20 in research and 62 in primary care medicine He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACP)". Joseph Cofrancesco is a published doctor. He published 53 publications, including: 'Testosterone replacement treatment options for HIV-infected men.' He is registered with Medicare and accepts Medicare payments.
Publications
- Clinician-educators in emerging graduate medical education systems: description, roles and perceptions.
- Perceptions of Division Directors in General Internal Medicine About the Importance of and Support for Scholarly Work Done by Clinician-Educators.
- The "new normal"-reply.
- Effect of the 2011 vs 2003 duty hour regulation-compliant models on sleep duration, trainee education, and continuity of patient care among internal medicine house sta...
- Long-Term Cocaine Use and Antiretroviral Therapy Are Associated with Silent Coronary Artery Disease in African Americans with HIV Infection Who Have No Cardiovascular ...
- HIV care and general internal medicine: the next generation.
- Treatment of HIV related weight loss.
- Introduction of evidence-based medicine into an ambulatory clinical clerkship.
- Gonadal hormone levels in injection drug users.
- Recrudescence of cutaneous Mycobacterium haemophilum lesions following tetanus immunization.
- The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection.
- Testosterone replacement treatment options for HIV-infected men.
- Promotion criteria for clinician-educators in the United States and Canada. A survey of promotion committee chairpersons.
- Body shape and composition in HIV-infected women: an urban cohort.
- Morphologic and metabolic changes associated with HIV therapy.
- Update from the 3rd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV.
- Medical Student and Faculty Perceptions of Volunteer Outpatients Versus Simulated Patients in Communication Skills Training.
- Provider and Practice Characteristics Associated with Use of Rapid HIV Testing by General Internists.
- General Internists' Beliefs, Behaviors, and Perceived Barriers to Routine HIV Screening in Primary Care.
- Update in HIV Medicine for the Generalist.
- Prevalence of low bone mineral density in a low-income inner-city population.
- Regional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophy.
- A multicenter study of internal medicine residents' perceptions of training, competence, and performance in outpatient HIV care.
- Long-term combination antiretroviral therapy is associated with the risk of coronary plaques in African Americans with HIV infection.
- Lipodystrophy in the patient with HIV: social, psychological, and treatment considerations.
- Treatment options for HIV-associated central fat accumulation.
- Impact of duty hour regulations on medical students' education: views of key clinical faculty.
- Illicit drug use and HIV treatment outcomes in a US cohort.
- Body shape and metabolic abnormalities in Thai HIV-infected patients.
- Chronic CD4+ T-cell activation and depletion in human immunodeficiency virus type 1 infection: type I interferon-mediated disruption of T-cell dynamics.
- Effect of residency duty-hour limits: views of key clinical faculty.
- Body composition, gender, and illicit drug use in an urban cohort.
- Update in HIV care.
- Stability of the latent reservoir for HIV-1 in patients receiving valproic acid.
- Metabolic abnormalities in HIV-infected patients: an update.
- Prevalence of complementary and alternative medicine use among HIV patients for perceived lipodystrophy.
- The effects of illicit drug use and HIV infection on sex hormone levels in women.
- Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circ...
- Marked intraindividual variability in antiretroviral concentrations may limit the utility of therapeutic drug monitoring.
- Report from the International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV.
- Injection drug use and HIV transmission in Russia.
- Psychological distress and physical pain appear to have no short-term adverse impact on plasma HIV-1 RNA levels in patients on successful HAART.
- 3rd IAS conference: metabolic and fat metabolism issues.
- Report from Boston: the 12th Conference on Retroviruses and Opportunistic Infections (CROI). February 22-25, 2005. Complications/toxicity of HIV therapy.
- Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART.
- Questionnaires to measure sexual quality of life.
- Management options for facial lipoatrophy.
- Genotypic resistance in HIV-1-infected patients with persistently detectable low-level viremia while receiving highly active antiretroviral therapy.
- Report from San Francisco: The 11th Conference on Retroviruses and Opportunistic Infections (CROI). Lipodystrophy and metabolic complications.
- Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1.
- Basic lipids: NCEP made easy for HIV patients.
- Promotion criteria for clinician-educators.
Schools
MT SINAI SCH OF MED OF NY UNIV
Columbia Presby Med Center
Montefiore Med Center
Johns Hopkins
Doctors Specialties
Accepted Insurances
- Blue Card PPO
- Blue Choice Advantage
- Blue Choice Network POS
- Blue Preferred PPO
- CareFirst Maryland POS
- Great West Healthcare-Cigna PPO
- Southern Health PPO
- Coventry Health Care of Delaware PPO
- First Health (Coventry Health Care) PPO
- Geisinger Health Plan
- Choice Care PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Options PPO
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACP)
Education
-
Johns Hopkins University
-
Albert Einstein College of Medicine
-
New York Presbyterian Hospital - Columbia Campus
-
Icahn School of Medicine at Mount Sinai
Hospital
-
Johns Hopkins Hospital
Drug Facts
| NPI NUMBER |
|
1144272055 |
| NPPES Provider LastName |
|
COFRANCESCO |
| NPPES Provider FirstName |
|
JOSEPH |
| NPPES Provider ZIPCode |
|
212870005 |
| NPPES Provider State |
|
MD |
| Specialty Description |
|
Internal Medicine |
| Total Claim Count |
|
1848.0 |
| Distinct Opioid Count |
|
0.0 |
| Opioid Claim Count |
|
0.0 |
| Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1144272055 |
| Last Name Of The Provider |
COFRANCESCO |
| First Name Of The Provider |
JOSEPH |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.